Actinomycin D
Therapeutic Group
Anti-neoplasticsIndication Dosage
Actinomycin D is a medication used to treat certain types of cancer. It works by stopping the growth of cancer cells in the body.
Choriocarcinoma, Ovarian Teratoma, Wilms Tumour, Rhabdomyosarcoma, Testicular Teratoma, Ewing's Sarcoma, Neuroblastoma (adjunct):
- Adults: 2.5 Mg/m2 In Divided Doses, Over 1 Week, Repeated Every 2 Weeks Or 0.75-2 Mg/m2 Every 1-4 Weeks Or 400-600 Mg/m2/day For 5 Days, Repeated Every 3-6 Weeks. Refer To Individual Protocol.
Content
- Inj: actinomycin D 0.5mg Per 3 ml Vial.
Pregnancy
Positive Evidence Of Risk: Avoid
Stability
- Cytotoxic Antibiotic
Contra Indications
- Patients With Concurrent Or Recent Chickenpox Or Herpes Zoster, Anaphylactic Reaction
Precautions
- Patients With Concurrent Or Recent Chickenpox Or Herpes Zoster, Anaphylactic Reaction
Lactation
- Contraindicated. Discontinue Breast Feeding
Side Effects
- Radiosensitization Effects
- Bone Marrow Suppression
- Neutropenic Fever
- Anaphylactic Reaction
- Fatigue
- Alopecia (reversible)
- Stevens-johnson Syndrome
- Growth Retardation
- Hyperuricemia
- Abdominal Pain
- Anorexia
- Diarrhoea
- Gi Ulceration
- Nausea
- Vomiting
- Anaemia
- Increased Bilirubin
- Hepatotoxicity
- Liver Function Test Abnor-mality
- Erythema Oedema
- Myaliga.